← Back to Clinical Trials
Recruiting NCT07394673

NCT07394673 Ultrasound-Guided Serratus Posterior Superior Intercostal Plane Block for Analgesia in Arthroscopic Shoulder Surgery

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07394673
Status Recruiting
Phase —
Sponsor Bursa City Hospital
Condition Postoperative Pain, Acute
Study Type INTERVENTIONAL
Enrollment 80 participants
Start Date 2026-02-20
Primary Completion 2026-09-20

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 65 Years
Study Type INTERVENTIONAL
Interventions
Group SPSIP: Serratus Posterior Superior İntercostal Plane Block (SPSIP)

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 80 participants in total. It began in 2026-02-20 with a primary completion date of 2026-09-20.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study aimed to evaluate the effectiveness of serratus posterior superior intercostal plane (SPSIP) block in managing postoperative pain in patients undergoing arthroscopic shoulder surgery.

Eligibility Criteria

Inclusion Criteria: * Classified as American Society of Anesthesiologists (ASA) physical status I-II-III * Scheduled for elective shoulder arthroscopy surgery * Surgery performed under general anesthesia * Provision of written informed consent Exclusion Criteria: * Use of anticoagulant or antiplatelet medications * Presence of bleeding diathesis or coagulation disorders * Known allergy or hypersensitivity to local anesthetics or opioid medications * Infection or history of previous surgery at the planned block site * Alcohol or drug dependence * Cognitive impairment preventing reliable pain assessment using the NRS * Pregnancy or lactation * Diabetes mellitus * Renal or hepatic impairment

Contact & Investigator

Central Contact

Mursel Ekinci, Assoc prof, MD

✉ drmurselekinci@gmail.com

📞 +905067137596

Principal Investigator

Merih Yıldız Eglen, MD

PRINCIPAL INVESTIGATOR

Bursa City Hospital

Frequently Asked Questions

Who can join the NCT07394673 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Postoperative Pain, Acute. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07394673 currently recruiting?

Yes, NCT07394673 is actively recruiting participants. Contact the research team at drmurselekinci@gmail.com for enrollment information.

Where is the NCT07394673 trial being conducted?

This trial is being conducted at Bursa, Turkey (Türkiye).

Who is sponsoring the NCT07394673 clinical trial?

NCT07394673 is sponsored by Bursa City Hospital. The principal investigator is Merih Yıldız Eglen, MD at Bursa City Hospital. The trial plans to enroll 80 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology